Global Autoimmune Disease Diagnostics Market Outlook Report to 2028, with Profiles of Abbott, Beckman Coulter, BioMerieux, Siemens Healthcare, F. Hoffmann-La Roche and Thermo Fisher Scientific

News provided by

Dec 29, 2023, 06:30 ET

DUBLIN, Dec. 29, 2023 /PRNewswire/ -- The "Autoimmune Disease Diagnostics: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global autoimmune disease diagnostics market was valued at nearly $14.2 billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of 3.9%, reaching $17.9 billion by 2028. A worldwide technological advancement in detecting autoimmune diseases fuels growth in this market.

In 2022, the enzyme-linked immunosorbent assay (ELISA) segment held the highest market share at about 31.5%, followed by Indirect immunofluorescence (IIF) at 26.4% and immunoblot at 20.2%.

This report aims to study the autoimmune disease diagnostics global market size comprehensively. Current and historical market revenues can be estimated based on the technology, by indication, gender and region.

The Report Includes

41 data tables and 30 additional tables
An overview of the global market landscape related to the autoimmune disease diagnostics
In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
Evaluation of the current market size and revenue growth prospects specific to autoimmune disease diagnostics, accompanied by a comprehensive market share analysis categorized by technology, indication, gender, and geographical region
Detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into new diagnostic pathway for autoimmune and inflammatory disorders
Discussion on role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results
Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies
Coverage of emerging technologies in autoimmune disease diagnostics, recent developments, future opportunities, patent review, and ESG trends
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Detailed profiles of leading market participants, including Abbott, Beckman Coulter Inc., BioMerieux, Siemens Healthcare, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Market Outlook
Market Summary

Chapter 3 Market Overview and Definitions

Overview: Autoimmune Disease Diagnostics
Enzyme-|Linked Immunosorbent Assay (ELISA)
Indirect Immunofluorescence (IIF)
Multiplex Immunoassays
Western Blot (Immunoblot)
Other Technologies
Indications
Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
Psoriatic Arthritis
Multiple Sclerosis
Inflammatory Bowel Disease
The Global Regulatory Structure for Autoimmune Disease Diagnostics
Test Validation
FDA Clearance or Approval
Good Manufacturing Practices (GMP)
Labeling and Instructions
Post-Market Surveillance
Quality Control and Quality Assurance
Clinical Utility and Medical Guidelines
Privacy and Data Security
Regulatory Scenario

Chapter 4 Market Dynamics

Chapter 5 Market Breakdown by Region

Chapter 6 Market Breakdown by Gender

Male
Female

Chapter 7 Market Breakdown by Indication

Type 1 Diabetes
Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
Psoriasis/Psoriatic Arthritis
Multiple Sclerosis
Inflammatory Bowel Disease

Chapter 8 Market Breakdown by Technology

Enzyme-Linked Immunosorbent Assay (ELISA)
Indirect Immunofluorescence (IIF)
Immunoblot
Multiplex Immunoassays

Chapter 9 ESG Development

Environment
- Research Practices
- Supply Chain Sustainability
- Waste Management
- Energy Efficiency
Social
- Access to Healthcare
- Patient Well-Being
- Community Engagement
Governance
- Ethical Business Practices
- Compliance with Regulations
- Board Diversity
- Transparency and Accountability
Case Study
- Roche
- Sustainability at Roche
Concluding Remarks

Chapter 10 Emerging Trends and Technologies

Chapter 11 Competitive Landscape

Chapter 12 Patent Analysis

Chapter 13 Pipeline Analysis

Chapter 14 M&A and Venture Funding Outlook

Chapter 15 Company Profiles

Abbott
BD Biosciences
Beckman Coulter
Biomerieux
Bio-Rad
F. Hoffmann-La Roche
Quest Diagnostics
Siemens Healthcare
Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/r/325lpk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets